America's senators have missed an enormous opportunity to give their citizens genuine protection against a pharmaceutical industry that is all too rarely brought to account.  Instead they voted overwhelmingly in favour of moves that draw the industry and the drug regulator, the Food and Drug Administration, even closer together. The ...